News

Caliper Life sciences, has launched two new products that expand the LabChip GX product line: a GLP/GMP-compliant version of the operating software for the LabChip GX instrument that

Solasia Pharma (Solasia) has completed phase I clinical trial for SP-01 (extended release transdermal granisetron patch, brand name: Sancuso ) in Japanese volunteers. Sancuso is the first and

Prasco Laboratories has entered into agreements with Winthrop US, a business of sanofi-aventis US. As per the agreemnts, it is expected to provide sales support and distribution services

Schering-Plough has reported interim results from an ongoing phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor. Narlaprevir demonstrated potent antiviral activity in treatment-naive patients

Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) reported that Benlysta (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal phase 3 trials in seropositive patients

PRA International opened a new office facility in Seoul, South Korea. To accommodate rapid growth and further broaden PRA’s ability to deliver clinical service excellence, the company has

Gilead Sciences (Gilead), in collaboration with GlaxoSmithKline (GSK) has announced plans for an international, event-driven (morbidity and mortality) clinical trial to study combination therapy versus monotherapy in a

Sosei Group (Sosei) has entered into a definitive distribution agreement with ASKA Pharmaceuticals (ASKA) for the commercialisation of the emergency contraceptive pill SOH-075 (NorLevo). NorLevo is an oral

Usana Health Sciences (Usana) has launched seasonal Vitamin D supplement. The supplement will be available every year from November to March. The company claimed that its supplement has